Lung Clinical Trials
BMS CA 209-568 1st Line Stage 4 NSCLC combination treatment of Yervoy with Opdivo currently with 8 patients enrolled. These patients started as early as July 2016 and all the patients continue to have either stable disease or partial responses on their respective CT scans – enrollment on hold and anticipated to reopen this quarter
Merck 407 is our 1st line metastatic NSCLC in the squamous cell type with Keytruda. Currently have 1 patient on treatment with a partial response recorded – Currently enrolling
BMS CA 209-370 1st Line metastatic NSCLC with Xalkori and Nivolumab. Successfully enrolled 1 patient in this cohort with partial response to disease noted. Patient was on treatment for 3 months however BMS pulled the plug doe to safety signals noted for hepato-toxicity. Note our patient is the only patient that did not have hepato-toxicity on the combination treatment – Enrollment closed
BMS CA 209-370 1st Line Metastatic NSCLC with Nivolumab. Successfully enrolled 2 patients with both patients having 2 months of stable disease while on treatment. – Enrollment closed
Roche GO 29436 1st Line Stage 4 NSCLC with Atezolizumab – Enrollment closed prior to our site enrolling a patient
BMS CA 209 -384 Nivolumab frequency in NSCLC patients – currently enrolling
Send UsA Message
I am currently undergoing treatment for breast cancer at Roper St. Francis Hospital and would like to acknowledge two physicians who truly embody your mission of “healing with compassion, faith and excellence”.
Please join Charleston Oncology and the American Association for Cancer Research (AACR) in support of National Survivor Month, celebrating those who have fought the disease and those currently in treatment.
June is National Cancer Survivor Month and throughout the month we are honoring our brave patients and sharing their inspirational stories.
May is Skin Cancer Awareness Month. Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Watch the video to learn more about melanoma from Charleston Oncology’s Dr. Charles S. Holladay.
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Dr. Shelly Shand shares important tips for diagnosing breast cancer early and the latest advancements in breast cancer.